Category: Vaccines
India Vaccines
-
Global Dengue Vaccine Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Segment Forecasts, 2023 – 2030 The Global Dengue Vaccine Market was valued around US $390.55 million in 2022 and is expected to reach US $1292.20 million by 2030 with a CAGR of 16.13% during the ... Read More
-
India Human Papillomavirus Vaccine Market Assessment, By Type [Bivalent, Quadrivalent, Nonavalent], By Disease Indication [Cervical Cancer, Anal Cancer, Vulvar and Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Others], By Method of synthesis [Nucleic acid-based, Peptide-based, Protein-based, Cell-based, Live-vector Vaccine], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy, Non-Governmental Organisations], By Region, Opportunities and Forecast, FY2017-FY2031F
... Cell-based, Live-vector Vaccine], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy, Non-Governmental Organisations], By Region, Opportunities and Forecast, FY2017-FY2031F India human papillomavirus vaccine market is projected to witness a CAGR of 11% during the forecast ... Read More
-
India Monkeypox Vaccine and Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the India market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the India market. Also, factors that are driving and restraining the monkeypox vaccine and treatment ... Read More
-
India Pneumococcal Vaccines Market : Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the India market. Also, factors that are driving and restraining the pneumococcal vaccines market are highlighted in the ... Read More
-
India Malaria Vaccine Market
... growth during the forecast period, 2024-2028. Rising awareness among people for early detection and treatments coupled with the rising number of people suffering from malaria are expected to augment the growth of the India malaria ... Read More
-
India Human Papillomavirus Vaccine Market By Valence (Bivalent, Quadrivalent, Nonvalent, and Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, and Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, and Others), and By Region and Competition, Forecast & Opportunities, 2029
... Non-Governmental Organizations, Public & Private Alliances, and Others), and By Region and Competition, Forecast & Opportunities, 2029 India human papillomavirus (HPV) vaccine market is anticipated to witness impressive growth during the forecast period. This can ... Read More
-
India Vaccines Market Overview, 2028
... 2012 India's pharmaceutical industry market value has been growing significantly. The vaccine storage temperature and cold chain logistics play a large role in how India is able to safely deliver life-saving vaccines all across the ... Read More
-
India Malaria Vaccine Market Assessment, By Agent [Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale, Plasmodium Knowlesi], By Stage Targeted [Pre-erythrocytic vaccines, Erythrocytic vaccines, Transmission-blocking vaccines, By Type of Vaccine [Whole Organism Vaccine and Protein Subunit Vaccine], By Technology [mRNA and Recombinant], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031
... to the WHO, India had a significant share in global malaria cases and deaths in 2021. India accounted for about 4% of global malaria cases and 7% of malaria deaths in 2021. The India malaria ... Read More
-
India Pneumococcal Vaccine Market Assessment, By Type of Vaccine [Live attenuated vaccine, Inactivated vaccine and Subunit vaccine], By Adjuvant [Adjuvanted and Non-adjuvanted], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By Age group [Infants, Children and Adult], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031
... and Adult], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031 India Pneumococcal Vaccine Market size was valued at ... Read More
-
India Influenza Vaccine Market Assessment, By Type of Vaccine [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2017-2031F
... Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2017-2031F India Influenza Vaccine market size ... Read More
-
Animal Healthcare Market (Animal Type: Bovine, Porcine, Ovine, and Poultry; Therapeutic Type: Drugs and Vaccines) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... SA Boehringer Ingelheim GmbH Merial Ltd. Ceva Sante Animale Merck & Co. Inc. Elanco Products Company Bayer AG Countries India Forecast Year (first) - 2022 Forecast Year (last) - 2031 Forecast Year ( first) Value ... Read More
-
India Immuno-Oncology Drugs Market, by Drug Type (Immune Checkpoint Inhibitors (Nivolumab, Atezolimumab, Pembrolizumab, Durvalumab), Monoclonal Antibodies (Rituximab, Trastazumab, Bevacizumab , Nimotuzumab, Pertuzumab, Ado-Trastuzumab Emtansine ), and Cancer Vaccines (Gardasil, Cervarix), by Cancer Type (Lung Cancer, Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity ... Read More
-
Sectoral Capsule-Vaccines Market in India (2009-2018)
... 39,496 years, where DALY isthe number of years lost due to poor health, disability and early deaths. For the year, India’smortality count stood at 1,800. The major segments of the Indian vaccine market are UniversalImmunization ... Read More
Research Assistance
